Pacific Biosciences of California, Inc. (PACB): Capital Expenditures
$2.71M
Year ended 2025-12-31
$5.37M
Trailing 12 months to 2026-06-30
-45.5%
3-year compound annual growth
+21.2%
5-year compound annual growth
-1.0%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.71M | -56.1% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $6.19M | -30.0% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $8.84M | -47.2% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $16.75M | +182.4% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | $5.93M | +470.8% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $1.04M | -63.4% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $2.84M | +53.0% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $1.85M | -82.2% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $10.43M | +27.1% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $8.21M | +172.7% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $3.01M | +87.0% | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | $1.61M | +77.0% | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | $909.0K | -46.6% | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | $1.70M | -81.7% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $9.28M | +76.5% | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | $5.26M | +1.6% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $5.18M | n/a | 2012-03-01, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $2.71M | -56.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $2.61M | -22.4% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $4.08M | +15.9% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $1.26M | -52.4% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $955.0K | +58.6% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $5.93M | -52.1% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $850.0K | -37.7% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $3.28M | -19.1% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $326.0K | +46.2% |
Compare PACB, QTRX, CTKB, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗